GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹699 Cr | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr |
What is the latest Profit After Tax of GLAND PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹699 Cr |
| Mar2025 | ₹772 Cr |
| Mar2024 | ₹781 Cr |
| Mar2023 | ₹1,212 Cr |
| Mar2022 | ₹997 Cr |
How is Profit After Tax of GLAND PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹699 Cr | -9.57 | |
| Mar2025 | ₹772 Cr | -1.10 | |
| Mar2024 | ₹781 Cr | -35.54 | |
| Mar2023 | ₹1,212 Cr | 21.54 | |
| Mar2022 | ₹997 Cr | - | |
Compare Profit After Tax of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,955.3 Cr | 2.4% | 1.8% | 57.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.4% |
1.8% |
57.9% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses